M. Catalán

1.4k total citations
37 papers, 670 citations indexed

About

M. Catalán is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, M. Catalán has authored 37 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Epidemiology and 7 papers in Pharmacology. Recurrent topics in M. Catalán's work include Antifungal resistance and susceptibility (10 papers), Sepsis Diagnosis and Treatment (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). M. Catalán is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Sepsis Diagnosis and Treatment (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). M. Catalán collaborates with scholars based in Spain and United States. M. Catalán's co-authors include Juan Carlos Montejo, Marı́a D. Moragues, José Pontón, Carlos Lumbreras, Francisco Álvarez-Lerma, Amalia del Palacio, Joshi Acosta, Manuel Lizasoaín, Francisco López‐Medrano and Rafael San Juan and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Clinical Pharmacology & Therapeutics and Intensive Care Medicine.

In The Last Decade

M. Catalán

34 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Catalán Spain 14 428 304 104 75 62 37 670
Anton S. M. Dofferhoff Netherlands 12 296 0.7× 173 0.6× 92 0.9× 127 1.7× 40 0.6× 17 688
Frantzeska Frantzeskaki Greece 14 272 0.6× 448 1.5× 79 0.8× 88 1.2× 141 2.3× 40 964
Fabian Dusse Germany 11 364 0.9× 246 0.8× 69 0.7× 63 0.8× 203 3.3× 46 846
Angelos Pefanis Greece 15 161 0.4× 388 1.3× 33 0.3× 42 0.6× 81 1.3× 40 771
Vildan Avkan-Oğuz Türkiye 14 205 0.5× 222 0.7× 42 0.4× 51 0.7× 57 0.9× 65 534
Elisa Barbieri Italy 14 214 0.5× 315 1.0× 51 0.5× 165 2.2× 97 1.6× 69 784
Ivana Milošević Serbia 14 207 0.5× 350 1.2× 42 0.4× 30 0.4× 34 0.5× 56 802
Rébecca Hamidfar-Roy France 13 234 0.5× 335 1.1× 37 0.4× 43 0.6× 193 3.1× 20 834
María Fernanda González-Lara Mexico 14 1.0k 2.4× 267 0.9× 521 5.0× 80 1.1× 123 2.0× 47 1.4k
Kübra Aykaç Türkiye 14 185 0.4× 182 0.6× 57 0.5× 33 0.4× 106 1.7× 56 616

Countries citing papers authored by M. Catalán

Since Specialization
Citations

This map shows the geographic impact of M. Catalán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Catalán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Catalán more than expected).

Fields of papers citing papers by M. Catalán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Catalán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Catalán. The network helps show where M. Catalán may publish in the future.

Co-authorship network of co-authors of M. Catalán

This figure shows the co-authorship network connecting the top 25 collaborators of M. Catalán. A scholar is included among the top collaborators of M. Catalán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Catalán. M. Catalán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lalueza, Antonio, Jaime Lora‐Tamayo, C. de la Calle, et al.. (2021). The early use of sepsis scores to predict respiratory failure and mortality in non-ICU patients with COVID-19. Revista Clínica Española (English Edition). 222(5). 293–298. 12 indexed citations
2.
Laguna‐Goya, Rocío, Alberto Utrero‐Rico, Paloma Talayero, et al.. (2020). IL-6–based mortality risk model for hospitalized patients with COVID-19. Journal of Allergy and Clinical Immunology. 146(4). 799–807.e9. 126 indexed citations
3.
Álvarez-Lerma, Francisco, R. Gimeno, M. Catalán, et al.. (2019). Changes of resistance rates in Pseudomonas aeruginosa strains are unrelated to antimicrobial consumption in ICU populations with invasive device-related infection. Medicina Intensiva. 44(7). 399–408. 4 indexed citations
4.
Álvarez-Lerma, Francisco, Mercedes Palomar-Martínez, M. Catalán, et al.. (2018). Invasive device-associated infections caused by Pseudomonas aeruginosa in critically ill patients: evolution over 10 years. Journal of Hospital Infection. 100(3). e204–e208. 9 indexed citations
5.
Álvarez-Lerma, Francisco, et al.. (2018). ¿Es necesario un proyecto para prevenir las infecciones del tracto urinario en los pacientes ingresados en unidades de cuidados intensivos españolas?. Medicina Intensiva. 43(2). 63–72. 10 indexed citations
6.
Olaechea, Pedro, Francisco Álvarez-Lerma, Mercedes Palomar, et al.. (2015). Characteristics and outcomes of patients admitted to Spanish ICU: A prospective observational study from the ENVIN-HELICS registry (2006–2011). Medicina Intensiva. 40(4). 216–229. 13 indexed citations
7.
Nuvials, Xavier, Mercedes Palomar, Francisco Álvarez-Lerma, et al.. (2015). Health-care associated infections. Patient characteristics and influence on the clinical outcome of patients admitted to icu. envin-helics registry data. Intensive Care Medicine Experimental. 3(S1). 5 indexed citations
8.
Álvarez-Lerma, Francisco, et al.. (2014). Estudio epidemiológico de infección por Clostridium difficile en pacientes críticos ingresados en una Unidad de Cuidados Intensivos. Medicina Intensiva. 38(9). 558–566. 12 indexed citations
9.
Olaechea, Pedro, Mercedes Palomar, Francisco Álvarez-Lerma, et al.. (2014). Análisis comparativo de pacientes ingresados en Unidades de Cuidados Intensivos españolas por causa médica y quirúrgica. Medicina Intensiva. 39(5). 279–289. 12 indexed citations
10.
Álvarez-Lerma, Francisco, et al.. (2013). Efectividad de anfotericina B liposomal en pacientes ingresados en UCI con técnicas de reemplazo renal. Revista española de quimioterapia. Suplemento. 26(4). 360–368. 5 indexed citations
11.
Álvarez-Lerma, Francisco, Cruz Soriano, M. Catalán, et al.. (2012). Impacto de anfotericina B liposomal en la función renal en pacientes críticos con la función renal deteriorada. Revista española de quimioterapia. Suplemento. 25(3). 206–215. 8 indexed citations
12.
Aguado, José María, Evaristo Varó, Asunción Moreno, et al.. (2012). Safety of anidulafungin in solid organ transplant recipients. Liver Transplantation. 18(6). 680–685. 20 indexed citations
13.
Acosta, Joshi, M. Catalán, Juan Carlos Montejo, et al.. (2011). Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease. European Journal of Clinical Microbiology & Infectious Diseases. 31(5). 721–731. 37 indexed citations
14.
Alhambra, Almudena, M. Catalán, Marı́a D. Moragues, et al.. (2008). Aislamiento de Aspergillus lentulus en España en un paciente crítico con enfermedad pulmonar obstructiva crónica. Revista Iberoamericana de Micología. 25(4). 246–249. 41 indexed citations
15.
Catalán, M. & Juan Carlos Montejo. (2006). Antifúngicos sistémicos. Farmacodinamia y farmacocinética. Revista Iberoamericana de Micología. 23(1). 39–49. 20 indexed citations
16.
Montejo, Juan Carlos, M. Catalán, & Amalia del Palacio. (2006). Medidas de prevención de la candidiasis invasora en el paciente crítico no neutropénico. Revista Iberoamericana de Micología. 23(1). 32–34.
17.
Rello, Jordi, et al.. (2002). Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia. Intensive Care Medicine. 28(8). 1030–1035. 42 indexed citations
18.
Catalán, M., et al.. (1998). Plasmapheresis as Therapy to Resolve Vascular Rejection in Heart Transplantation With Severe Heart Failure: “A Report of One Case”. Transplantation Proceedings. 30(1). 176–179. 1 indexed citations
19.
Belda, J., et al.. (1995). Seudoquistes pulmonares traumáticos. Archivos de Bronconeumología. 31(10). 534–536. 1 indexed citations
20.
Perea, José Ramón Azanza, et al.. (1992). Possible interaction between cyclosporine and josamycin: A description of three cases. Clinical Pharmacology & Therapeutics. 51(5). 572–575. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anton S. M. Dofferhoff Breakdown of academic impact, for papers by Frantzeska Frantzeskaki Breakdown of academic impact, for papers by Fabian Dusse Breakdown of academic impact, for papers by Angelos Pefanis Breakdown of academic impact, for papers by Vildan Avkan-Oğuz Breakdown of academic impact, for papers by Elisa Barbieri Breakdown of academic impact, for papers by Ivana Milošević Breakdown of academic impact, for papers by Rébecca Hamidfar-Roy Breakdown of academic impact, for papers by María Fernanda González-Lara Breakdown of academic impact, for papers by Kübra Aykaç
Rankless by CCL
2026